Improvement of 11 patients with nail psoriasis with apremilast: Results of an investigator-initiated open-label study - 09/11/20
Doi : 10.1016/j.jaad.2020.05.087
Allen S.W. Oak, MD, Hoang Ho-Pham, MD, Boni E. Elewski, MD ⁎ 
Department of Dermatology, The University of Alabama at Birmingham, Birmingham, Alabama
∗Correspondence and reprint requests to: Boni E. Elewski, MD, Faculty Office Tower, 510 20th St South, Department of Dermatology, Ste 858, Birmingham, AL 35233Faculty Office Tower, 510 20th St South, Department of DermatologySte 858BirminghamAL35233
| Funding sources: Amgen (previously Celgene). |
|
| Conflicts of interest: Dr Elewski is an investigator for AbbVie, AnaptysBio, Boehringer Ingelheim, Bristol-Myers Squibb, Amgen (previously Celgene), Incyte, LEO Pharma, Lilly, Merck, Menlo, Novartis, Pfizer, Regeneron, Sun, Valeant (Ortho Dermatology), and Vanda, and is a consultant for Boehringer Ingelheim, Bristol-Myers Squibb, Amgen (previously Celgene), LEO Pharma, Lilly, Menlo, Novartis, Pfizer, Sun, Valeant (Ortho Dermatology), and Verrica. Drs Oak and Ho-Pham have no conflicts of interest to declare. |
|
| IRB approval status: Reviewed and approved by The University of Alabama at Birmingham Institutional Review Board. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83 - N° 6
P. 1830-1832 - décembre 2020 Retour au numéro
Article précédent
- Epidemiology, treatment, survival, and prognostic factors of cutaneous mucoepidermoid carcinoma: A distinct entity with an indolent clinical course
- Fatima N. Mirza, Sara Yumeen, Cheryl K. Zogg, Humza N. Mirza, Jonathan S. Leventhal
- Outcomes in patients with extramammary Paget disease with brain metastasis: A retrospective analysis
- Takayuki Fusumae, Keitaro Fukuda, Ikuko Hirai, Yoshio Nakamura, Keiji Tanese, Takashi Iwata, Takeru Funakoshi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?